Fialuridine
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Other names | 2′-Fluoro-5-iodouracil |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| NIAID ChemDB | |
| Chemical and physical data | |
| Formula | C9H10FIN2O5 |
| Molar mass | 372.091 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
|
| |
Fialuridine, or 1-(2-deoxy-2-fluoro-1-D-arabinofuranosyl)-5-iodouracil (FIAU), is a nucleoside analogue that was investigated as a potential therapy for hepatitis B virus infection. In a 1993 clinical study at the NIH, unexpected toxicity led to the death of 5 out of 15 patients from liver failure alongside lactic acidosis; two further participants required liver transplantation. It is suspected that the toxicity of fialuridine was a result of mitochondrial damage caused by the incorporation of fialuridine into mitochondrial DNA via its 3'-hydroxyl moiety, leading to impaired DNA synthesis. This toxicity was unusual in that it was not predicted by animal studies.